According to recent filings covering the 90 days ending January 10, 2026, the three most significant insider holders at Kyverna Therapeutics are Director Fred E Cohen (4.54Mn shares), TenPercentOwner Sciences, Inc. Gilead (4.13Mn shares), TenPercentOwner Capital Life Sciences Investors, Llc Bain (3.16Mn shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Fred E Cohen | 4,540,558 | 02 Jun, 2025 | |
| Sciences, Inc. Gilead | 4,126,119 | 13 Feb, 2024 | |
| Capital Life Sciences Investors, Llc Bain | 3,163,868 | 14 Feb, 2024 | |
| Beth C Seidenberg | 885,951 | 02 Jun, 2025 | |
| Biopartners Opportunity Fund I, L.P. Westlake | 869,317 | 22 Dec, 2025 | |
| Biopartners Fund I, L.P. Westlake | 735,984 | 14 Feb, 2024 | |
| Ventures Iii Gp, Llc Northpond | 450,000 | 12 Feb, 2024 | |
| Ryan Alexander Jones | Chief Financial Officer | 55,950 | 15 Apr, 2025 |
| Karen Marie Walker | Chief Technology Officer | 22,636 | 17 Dec, 2025 |
| Mert Aktar | 16,634 | 02 Jun, 2025 | |
| Daniel K Spiegelman | 16,634 | 02 Jun, 2025 | |
| Ian T Clark | 16,634 | 02 Jun, 2025 | |
| Christi Shaw | 16,634 | 02 Jun, 2025 | |
| Ventures, Llc Vida | 583 | 14 Feb, 2024 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 18 Dec, 2025 | Beth C Seidenberg | Common Stock | A | 133,333 | $7.50 | 869,317 | I | P |
| 18 Dec, 2025 | Biopartners Opportunity Fund I, L.P. Westlake | Common Stock | A | 133,333 | $7.50 | 869,317 | I | P |
| 15 Dec, 2025 | Karen Marie Walker | Common Stock | A | 23,998 | $4.83 | 46,634 | D | M |
| 15 Dec, 2025 | Karen Marie Walker | Common Stock | D | 23,998 | $12.20 | 22,636 | D | S |
| 29 May, 2025 | Beth C Seidenberg | Common Stock | A | 16,634 | $0.00 | 16,634 | D | A |
| 29 May, 2025 | Beth C Seidenberg | - | - | 16,634 | D | |||
| 29 May, 2025 | Daniel K Spiegelman | Common Stock | A | 16,634 | $0.00 | 16,634 | D | A |
| 29 May, 2025 | Ian T Clark | Common Stock | A | 16,634 | $0.00 | 16,634 | D | A |
| 29 May, 2025 | Fred E Cohen | Common Stock | A | 16,634 | $0.00 | 16,634 | D | A |
| 29 May, 2025 | Christi Shaw | Common Stock | A | 16,634 | $0.00 | 16,634 | D | A |
| 29 May, 2025 | Mert Aktar | Common Stock | A | 16,634 | $0.00 | 16,634 | D | A |
| 11 Apr, 2025 | Ryan Alexander Jones | - | - | 55,950 | D | |||
| 11 Apr, 2025 | Ryan Alexander Jones | Common Stock | A | 12,000 | $0.00 | 55,950 | D | A |
| 11 Apr, 2025 | Karen Marie Walker | Common Stock | A | 13,000 | $0.00 | 22,636 | D | A |
| 06 Jun, 2024 | Karen Marie Walker | Common Stock | A | 9,636 | $4.42 | 9,636 | D | M |
| 28 May, 2024 | Ryan Alexander Jones | Common Stock | A | 10,870 | $0.73 | 36,804 | D | M |
| 28 May, 2024 | Ryan Alexander Jones | Common Stock | A | 7,146 | $0.73 | 43,950 | D | M |
| 12 Feb, 2024 | Sciences, Inc. Gilead | - | - | 4,126,119 | D | |||
| 12 Feb, 2024 | Sciences, Inc. Gilead | Common Stock | A | 910,000 | $22.00 | 4,126,119 | D | P |
| 12 Feb, 2024 | Sciences, Inc. Gilead | Common Stock | A | 3,216,119 | - | 3,216,119 | D | C |